OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AMBN54

Ambani Orgochem Ltd

Specialty ChemicalsVerified

Ambani Orgochem's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. Profitability and return metrics are not available for Ambani Orgochem, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or other key performance indicators. This lack of data limits the ability to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of Ambani Orgochem's revenue streams or its exposure to specific markets or regions. Growth trajectory is also unclear due to the absence of historical revenue data and forward-looking guidance. The outlook for the current and next fiscal years is not provided, making it difficult to evaluate the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk, as no balance-sheet inputs are available. Additionally, the company is flagged for potential liquidity risk, though the severity is not quantified. There is no indication of dilution risk, as shares outstanding remain unchanged between basic and diluted measures. Recent events and filings are not detailed in the available data, and no transcripts or disclosures are provided to inform on the company's recent operational or strategic developments.

30-day price · AMBN-6.40 (-4.6%)
Low$134.00High$143.90Close$134.00As of9 Jun, 00:00 UTC
Profile
CompanyAmbani Orgochem Ltd
TickerAMBN.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Ambani Orgochem Ltd is a specialty chemicals company engaged in the production and sale of chemical products, primarily serving industrial and consumer markets.

Classification. Ambani Orgochem is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a high confidence level of 0.92.

Ambani Orgochem's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. Profitability and return metrics are not available for Ambani Orgochem, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or other key performance indicators. This lack of data limits the ability to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of Ambani Orgochem's revenue streams or its exposure to specific markets or regions. Growth trajectory is also unclear due to the absence of historical revenue data and forward-looking guidance. The outlook for the current and next fiscal years is not provided, making it difficult to evaluate the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk, as no balance-sheet inputs are available. Additionally, the company is flagged for potential liquidity risk, though the severity is not quantified. There is no indication of dilution risk, as shares outstanding remain unchanged between basic and diluted measures. Recent events and filings are not detailed in the available data, and no transcripts or disclosures are provided to inform on the company's recent operational or strategic developments.
Key takeaways
  • Ambani Orgochem operates in the specialty chemicals industry, with a high classification confidence.
  • The company's liquidity and profitability metrics are not available, limiting the ability to assess its financial health.
  • Revenue concentration and geographic exposure are not disclosed, making it difficult to evaluate diversification.
  • Growth trajectory and risk factors are unclear due to the lack of detailed financial and operational data.
  • No recent events or filings are available to inform on the company's current status or strategic direction.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$866.7M$52.6M$17.0M-$32.0M
FY-3$1.25B$52.5M$20.1M-$86.5M
FY-2$1.32B$70.3M$19.8M-$351.7M
FY-1$1.36B-$7.7M$30.4M-$191.0M
FY0$1.93B$65.7M-$8.5M-$183.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$777.2M$185.3M$31.1M
FY-3$1.12B$363.7M$105.9M
FY-2$1.37B$376.6M$58.8M
FY-1$1.76B$520.3M$71.1M
FY0$2.08B$568.7M$162.2M
PeriodOCFCapExFCFSBC
FY-4$43.6M-$59.3M-$32.0M
FY-3-$394.5k-$120.8M-$86.5M
FY-2$171.3M-$386.0M-$351.7M
FY-1-$125.0M-$176.2M-$191.0M
FY0$108.2M-$201.0M-$183.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricAMBNActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 01:37 UTC#1b592cd5
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:37 UTCJob: 5de7855a